Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils

Inflammation

Volumn 26, Issue 3, 2002, Pages 111-119

  Kudlacz, Elizabeth ^a   Whitney, Carrie ^a   Andresen, Catharine ^a   Conklyn, Maryrose ^a  

^a PFIZER INC   (United States)

Author keywords

Adhesion molecules; Chemokine; Eosinophil; Eotaxin; Lung; Rodent

Indexed keywords

ACTIN; CD11B ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CYTOKINE; EOSINOPHIL PEROXIDASE; EOTAXIN; INTERLEUKIN 5; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OVALBUMIN; ALPHA4 INTEGRIN; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 3; CHEMOKINE RECEPTOR; EOSINOPHIL CHEMOTACTIC FACTOR; IMMUNOLOGICAL ADJUVANT;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; EOSINOPHIL; EOSINOPHILIA; FLUORESCENCE; INFLAMMATION; MOUSE; NONHUMAN; TRANSGENIC MOUSE; ANIMAL; ASTHMA; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL ADHESION MOLECULES; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; EOSINOPHILS; INTEGRIN ALPHA4; INTERLEUKIN-5; MICE; MICE, TRANSGENIC; RECEPTORS, CHEMOKINE; UP-REGULATION; ANIMALS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0036015049     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015548414274     Document Type: Article

References (35)

1. Pharmacology of the eosinophil
2. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
3. Evidence for a predominant "Th2-type" bronchoalveolar lavage T-lymphocyte population in atopic asthma
4. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma
5. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production
6. Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to interleukin-5, in monkeys
7. Effects of an antibody to interleukin-5 in a monkey model of asthma
8. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
9. Molecular basis for selective eosinophil trafficking in asthmatics: A multistep paradigm
10. Cell adhesion molecules and asthma
11. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo
12. Role of very late activation antigen-4 in the antigen-induced accumulation of eosinphils and lymphocytes in the lungs and airway lumen of sensitized brown Norway rats
13. Airway recruitment of leukocytes in mice is dependent on α4-integrins and vascular cell adhesion molecule-1
14. CCL chemokines and asthma
15. Eosinophil chemotacfic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics
16. Eotaxin: From an eosinophilic chemokine to a major regulator of allergic reactions
17. Migration of eosinophils across endothelial cell monolayers: Interactions among IL-5, endothelial-activating cytokines and C-C chemokines
18. Increased expression of eotaxtin in bronchoalveolar lavage and airways of asthmatics contributes to the site of inflammation
19. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
20. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
21. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors
22. Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin
23. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils
24. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge
25. Eosinophilia in transgenic mice expressing interleukin 5
26. Eosinophilopoeisis in a murine model of allergic airway eosinophilia: Involvement of bone marrow IL-5 and IL-5 receptor α
27. Very early detection of changes associated with cellular activation using a modified flow cytometer
28. Leukocyte-endothelial recognition: Three (or more) steps to specificity and diversity
29. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin
30. CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells
31. IL-5 up-regulated cysteinyl leukotriene-1 receptor expression in HL-60 cells differentiated into eosinophils
32. Eotaxin increases the expression of CD11b/CD18 and adhesion properties on IL5, but not fmlp-prestimulated human peripheral blood eosinophils
33. The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers
34. Overexpression of CD11b on eosinophils in atopic dermatitis: Downregulation by cyclosporin A and upregulation by interleukin 5
35. Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils. Characterization and functional relevance